Loading...
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
BACKGROUND: Bronchial asthma is an inflammatory disease of the airways. Beclomethasone dipropionate/Formoterol (BDP/F) and Fluticasone furoate/Vilanterol (FF/V) are two of the most effective LABA/ICS combinations for managing persistent bronchial asthma. Aim of the study was to compare the outcomes...
Na minha lista:
| Udgivet i: | Multidiscip Respir Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003157/ https://ncbi.nlm.nih.gov/pubmed/29946464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40248-018-0131-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|